Guoqin Zheng
YOU?
Author Swipe
View article: Ferroptosis Induced Following Iron Sucrose Injection into Ascites of Hepatocellular Carcinoma
Ferroptosis Induced Following Iron Sucrose Injection into Ascites of Hepatocellular Carcinoma Open
Most of advantage stages of HCC is going into cachexia with asictes which is lacking an effective treatment. Ferroptosis-Enhanced Immunotherapy is used for treating ascites of HCC by an chitosan hydrochloride and oxidized dextran (CH-OD) d…
View article: Hydralazine Induced Immunologic Response by scRNA-Seq with Olink Proteomics Associated with Survival Time of pancreatic cancer
Hydralazine Induced Immunologic Response by scRNA-Seq with Olink Proteomics Associated with Survival Time of pancreatic cancer Open
Background: Pancreatic cancer is a highly lethal cancer with no treatment options when diagnosed at an advanced stage. Hapten combined with chemotherapy drugs have been successfully injected into the tumor for local treatment of pancreatic…
View article: Hapten-Mediated Chemical Immune Therapy with Drug Administration into Cervical Cancer without Hysterectomy:Awakening Immune Cells for Immunotherapy
Hapten-Mediated Chemical Immune Therapy with Drug Administration into Cervical Cancer without Hysterectomy:Awakening Immune Cells for Immunotherapy Open
Background: Cervical cancer is one of the most common and deadly cancers in women, for whom with persistent infection of High-Risk Human Papillomavirus (HPV). Current treatment of cervical cancer involves radical hysterectomy, radiotherapy…
View article: Effect of sodium stibogluconate in recruiting and awakening immune cells in the pleural fluid of pancreatic cancer: preparation for immunotherapy
Effect of sodium stibogluconate in recruiting and awakening immune cells in the pleural fluid of pancreatic cancer: preparation for immunotherapy Open
Ascites and pleural effusion are recognized complications of pancreatic cancer. These diseases are accompanied by ascites and pleural effusion, and drug treatment is limited by high costs, long hospital stays, and failure rates. Immunother…
View article: Chemical immune conization of precancerous cervical lesions awakens immune cells and restores normal HPV negative and abnormal proliferation
Chemical immune conization of precancerous cervical lesions awakens immune cells and restores normal HPV negative and abnormal proliferation Open
Background Cervical cancer is one of the most common and deadly cancers in women, which is closely linked to the persistent infection of high-risk human papillomavirus (HPV). Current treatment of cervical cancer involves radical hysterecto…
View article: Successful targeting in situ of an oncogenic nuclear antigen by hapten induced tumor associated autoantibodies (iTAA)
Successful targeting in situ of an oncogenic nuclear antigen by hapten induced tumor associated autoantibodies (iTAA) Open
The abscopal is a hypothesis for treating of non-irradiated tumors after localized radiation therapy. It is associated with the products of tumor-associated gene as autoantibodies (aTAAs) in reaction to the tumor-associated antigens (TAAs)…
View article: scRNA-Seq Analysis Immune Changes of Intratumoral Hapten Plus Chemotherapy Drugs for the Treatment of Male Breast Cancer
scRNA-Seq Analysis Immune Changes of Intratumoral Hapten Plus Chemotherapy Drugs for the Treatment of Male Breast Cancer Open
Male breast cancer is a rare studied of disease and the relevant research is also very scarce. Current treatment of male breast cancer is modeled after the treatment of female breast cancer, namely a surgery-based comprehensive treatment, …
View article: Immune Reaction Induced with Hapten Enhanced Intratumoral Chemotherapy during Esophagectomy: Explore Possible Immunosurgery
Immune Reaction Induced with Hapten Enhanced Intratumoral Chemotherapy during Esophagectomy: Explore Possible Immunosurgery Open
Background: Surgery is one of the main treatments for esophageal cancer, which can rapidly reduce tumor burden. If the surgery can induce immune response and wake up immune cells, it may be possible to translate surgery into immunesurgery.…
View article: Awaken Immune Cells by Hapten Enhanced Intratumoral Chemotherapy with Penicillin Prolong Pancreatic Cancer Survival
Awaken Immune Cells by Hapten Enhanced Intratumoral Chemotherapy with Penicillin Prolong Pancreatic Cancer Survival Open
Intratumoral immunotherapy is well studied and is ongoing, but few studies have evaluated the relationship between of cytotoxic drugs intratumoral injection (CDI) and hapten-enhanced cytotoxic drugs intratumoral injection (HECDI) and patie…
View article: Long-term sequelae of different COVID-19 variants: The original strain versus the Omicron variant
Long-term sequelae of different COVID-19 variants: The original strain versus the Omicron variant Open
Although Omicron appears to cause less severe acute illness than the original strain, the potential for large numbers of patients to experience long COVID is a major concern. Little is known about the recovery phase in cases of Omicron, hi…
View article: Healthy outcomes of patients with COVID-19 two years after the infection: a prospective cohort study
Healthy outcomes of patients with COVID-19 two years after the infection: a prospective cohort study Open
The long-term effect of coronavirus disease 2019 (COVID-19) has been rarely known. This study aimed to investigate healthy outcomes of COVID-19 survivors up to 2 years after the infection. A total of 155 COVID-19 patients, who were dischar…
View article: Immunity Reaction by Chemotherapy Drug With DNP or penicillin Intratumoral Injection in Mice Bearing Tumor
Immunity Reaction by Chemotherapy Drug With DNP or penicillin Intratumoral Injection in Mice Bearing Tumor Open
Aim To observe the abscopal effect related to immunity reactions induced by an intratumoral injection of a chemotherapy drug with DNP or penicillin. Methods The C57BL/6 mice melanoma injected by a difference drug with DNP or penicillin and…
View article: Clinical status of patients 1 year after hospital discharge following recovery from COVID-19: a prospective cohort study
Clinical status of patients 1 year after hospital discharge following recovery from COVID-19: a prospective cohort study Open